Findings
A total of 211 patients (129 men, 82 women) were included in the study and the average age of them was 53.55 ± 17.81. The average age of male patients was 55.24 ± 17.21 while it was 50.90 ± 18.50 for women. The average hospitalization period of the patients was 19.3 days. In both women and men the group with multiple diseases constituted the majority and hypertension and diabetes were the most common comorbidities in patients, respectively (Table 1). When age, gender and comorbid diseases were considered, no significant difference was found between the groups with and without loss of smell. Anosmia developed in 50 (23.5%) patients, and hyposmia developed in 84 patients (40%).
No decrease or loss of sense of smell was observed in 77 patients in total. It was concluded that 26 (12.3%) of these patients used nasal steroids during the diagnosis (Table 2). It was found out that there was no decrease in sense of smell during and after Covid-19 infection. 14 of these patients were female (6.6%) and 12 were male (5.7%). (Table 1-2).